The Effect of Glycemic Control on Cardiac Outcomes in Saudi Diabetic Patients who Underwent Coronary Angiogram

Mohammed Ali Balghith1, Ahmed Ammar Almutairi1, Ibrahim Abdulelah Almohini1

  • 1King Abdulaziz Cardiac Center, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Insights

Poor glycemic control in diabetic patients undergoing cardiac procedures is linked to higher rates of percutaneous coronary intervention (PCI) and readmissions. Coronary artery bypass graft (CABG) surgery was associated with fewer complications.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Diabetes mellitus is a metabolic disorder affecting insulin secretion and cellular function.
  • Glycated hemoglobin (HbA1c) is a key indicator of long-term glucose control.
  • Diabetes increases the risk of cardiovascular complications, including acute coronary syndrome, often requiring interventions like PCI or CABG.

Purpose of the Study:

  • To assess the impact of glycemic control, measured by HbA1c, on cardiac complications in Saudi diabetic patients.
  • To compare outcomes between patients who underwent percutaneous coronary intervention (PCI) and Coronary Artery Bypass Graft (CABG).

Main Methods:

  • A retrospective cohort study involving 379 diabetic patients aged 50-70.
  • Patients were categorized based on HbA1c levels (<7.5% vs. ≥7.5%).
  • Data on HbA1c, intervention type, and cardiac outcomes were collected over a 3-year follow-up period. Excluded patients with renal failure, liver dysfunction, type 1 diabetes, or cancer.

Main Results:

  • Patients with uncontrolled HbA1c (≥7.5%) were more likely to undergo PCI (P=0.04).
  • The controlled HbA1c group showed a higher likelihood of receiving medical treatment (P=0.001).
  • Uncontrolled HbA1c post-intervention correlated with increased hospital readmissions (P=0.018).

Conclusions:

  • Elevated HbA1c levels in diabetic patients are associated with increased likelihood of PCI and higher readmission rates.
  • Coronary Artery Bypass Graft (CABG) was linked to a lower risk of cardiac complications.
  • Further research is needed to explore optimal diabetes management strategies for preventing adverse cardiovascular outcomes in this population.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
88
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
441
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
576
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
117
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
62
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
97